Approval · Notice of Compliance 3770 · 1997
ESTRING: Notice of Compliance 3770
Issued April 10, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3770
- Date
- April 10, 1997
- Company
- Pharmacia & Upjohn Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New claim: for continuous, long-term use
- Therapeutic class
- Estrogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESTRING | Not yet assigned | — |
Medicinal ingredients
- ESTRADIOL 2 MG per UNIT